Kenneth J Wilkins
Overview
Explore the profile of Kenneth J Wilkins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
385
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhatia A, Preiss A, Xiao X, Brannock M, Alexander G, Chew R, et al.
PLoS Med
. 2025 Jan;
22(1):e1004493.
PMID: 39823513
Background: Nirmatrelvir with ritonavir (Paxlovid) is indicated for patients with Coronavirus Disease 2019 (COVID-19) who are at risk for progression to severe disease due to the presence of one or...
2.
ONeil S, Madlock-Brown C, Wilkins K, McGrath B, Davis H, Assaf G, et al.
NPJ Digit Med
. 2024 Oct;
7(1):296.
PMID: 39433942
Post-Acute Sequelae of SARS-CoV-2 infection (PASC), also known as Long-COVID, encompasses a variety of complex and varied outcomes following COVID-19 infection that are still poorly understood. We clustered over 600...
3.
Ebenuwa I, Violet P, Tu H, Lee C, Munyan N, Wang Y, et al.
Cardiovasc Diabetol
. 2024 Oct;
23(1):370.
PMID: 39425096
Background: Reduced red blood cell deformability (RBCD) is associated with diabetic vascular complications, but early pathophysiological RBC changes and predictive demographic and clinical factors in populations with diabetes are unclear....
4.
Qin Q, Wilkins K, Jones S, Bradwell K, Chan L, Sun J, et al.
BMJ Public Health
. 2024 Oct;
2(1).
PMID: 39363958
Objectives: To evaluate the effectiveness of COVID-19 vaccinations (initial and booster) during pre-Delta, Delta, and Omicron dominant periods among pregnant people via (1) COVID-19 incident and severe infections among pregnant...
5.
Vaidya D, Wilkins K, Hurwitz E, Islam J, Li D, Sun J, et al.
J Clin Transl Sci
. 2024 Sep;
8(1):e107.
PMID: 39296577
Background: Leveraging the National COVID-19 Cohort Collaborative (N3C), a nationally sampled electronic health records repository, we explored associations between individual-level social determinants of health (SDoH) and COVID-19-related hospitalizations among racialized...
6.
Kimmel P, Fwu C, Nolin T, Schulman I, Givens S, Wilkins K, et al.
J Am Soc Nephrol
. 2024 Sep;
36(1):108-121.
PMID: 39226330
No abstract available.
7.
Wong R, Hall M, Wiggen T, Johnson S, Huling J, Turner L, et al.
Diabetes Care
. 2024 Aug;
47(10):1846-1854.
PMID: 39207804
Objective: The coronavirus 2019 (COVID-19) pandemic has evolved over time by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant, disease severity, treatment, and prevention. There is evidence of an elevated...
8.
ONeil S, Madlock-Brown C, Wilkins K, McGrath B, Davis H, Assaf G, et al.
medRxiv
. 2024 Jul;
PMID: 38947087
Post-Acute Sequelae of SARS-CoV-2 infection (PASC), also known as Long-COVID, encompasses a variety of complex and varied outcomes following COVID-19 infection that are still poorly understood. We clustered over 600...
9.
Coleman B, Casiraghi E, Callahan T, Blau H, Chan L, Laraway B, et al.
Transl Psychiatry
. 2024 Jun;
14(1):246.
PMID: 38851761
Acute COVID-19 infection can be followed by diverse clinical manifestations referred to as Post Acute Sequelae of SARS-CoV2 Infection (PASC). Studies have shown an increased risk of being diagnosed with...
10.
Faherty E, Wilkins K, Jones S, Challa A, Qin Q, Chan L, et al.
Vaccines (Basel)
. 2024 Mar;
12(3.
PMID: 38543923
COVID-19 vaccines have been shown to be effective in preventing severe illness, including among pregnant persons. The vaccines appear to be safe in pregnancy, supporting a continuously favorable overall risk/benefit...